Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Zhu, Wangyu ^a   He, Jianying ^a   Chen, Dongdong ^a   Zhang, Bingjie ^a   Xu, Liyun ^a   Ma, Haijie ^a   Liu, XiaoGuang ^a   Zhang, YongKui ^a   Le, Hanbo ^a  

^a Zhoushan Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 29C; MICRORNA 429; MICRORNA 93; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; AGED; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84895536213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087780     Document Type: Article

References (32)

1. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586-591.
2. Calin GA, Croce CM(2006)MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66:7390-7394. (Pubitemid 44289189)
3. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198. (Pubitemid 43357945)
4. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008)MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48-57.
5. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, et al. (2009)MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69:5776-5783.
6. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, et al. (2010) miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 70:1793-1803.
7. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28:1721-1726.
8. Heegaard NHH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2012) Circulating microRNA expression profiles in early stage non-small cell lung cancer. Int J Cancer 130:1378-1386.
9. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009)Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006.
11. Leskelä S, Leandro-García LJ, Mendiola M, Barriuso J, Inglada-Pérez L, et al. (2010) The miR-200 family controls {beta}-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer 18:85-95.
12. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, et al. (2010) miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death. Cancer Res 70:1793-1803.
13. Bianchi F, Nicassio F, Veronesi G, di Fiore PP (2012) Circulating microRNAs: next-generation biomarkers for early lung cancer detection. Ecancermedicalscience 6:246.
14. Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, et al.(2011) Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 4:575-586.
15. Zou Y, Wang L, Zhao C, Hu Y, Xu S, et al. (2013) CEA, SCC and NSE levels in exhaled breath condensate-possible markers for early detection of lung cancer. J Breath Res7:047101.
16. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010)Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50:298-301.
17. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518.
18. Zhu W, Liu X, He J, Chen D, Hunag Y, et al. (2011)Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11:393-402.
19. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257-2261. (Pubitemid 43271657)
20. Le HB, Zhu WY, Chen DD, He JY, Huang YY, et al. (2012) Evaluation of dynamic change of serum miR-21 and miR-24 in pre-and post-operative lung carcinoma patients. Med Oncol 29:3190-3197.
21. Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, et al. (2012)MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11:4352-4365.
22. Savita U, Karunagaran D(2013) MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (Non Small Cell Lung Cancer) cells. Biochem Biophys Res Commun 434:841-847.
23. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, et al. (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68:7846-7854.
24. Park SM, Gaur AB, Lengyel E, Peter ME(2008)The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907. (Pubitemid 351482843)
25. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008)The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601. (Pubitemid 351627379)
26. Skog J, Würdinger T, Van Rijn, Meijer DH, Gainche L, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476.
27. Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, et al. (2013) Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 132:1602-1612.
28. Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX, et al. (2012)A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate 72:1443-1452.
29. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127:118-126.
30. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, et al. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6:482-488.
31. Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF (2011) Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol Oncol 121:200-205.
32. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, et al. (2011)Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 8:506-516.